Загрузка...
Ephedrine treatment in congenital myasthenic syndrome due to mutations in DOK7 [Image: see text]
BACKGROUND: Mutations in the postsynaptic adaptor protein Dok-7 underlie congenital myasthenic syndrome (CMS) with a characteristic limb girdle pattern of muscle weakness. Patients usually do not respond to or worsen with the standard CMS treatments: cholinesterase inhibitors and 3,4-diaminopyridine...
Сохранить в:
| Главные авторы: | , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Academy of Neurology
2010
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2875925/ https://ncbi.nlm.nih.gov/pubmed/20458068 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0b013e3181dd43bf |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|